Local CpG-Stat3 siRNA treatment improves antitumor effects of checkpoint inhibitors
Yu, H.; Zhang, C.; Huang, R.; Ren, L.; Zhang, J.; Kortylewski, M.; Swiderski, P.; Forman, S.
Show abstract
Immune checkpoint blockade (ICB) therapy has significantly benefited patients with several types of solid tumors and some lymphomas. However, many of the treated patients do not have durable clinical response. It has been demonstrated that rescuing exhausted CD8+ T cells is required for ICB-mediated antitumor effects. We recently developed an immunostimulatory strategy based on silencing STAT3 while stimulating immune responses by CpG, ligand for Toll-like receptor 9 (TLR9). The CpG-small interfering RNA (siRNA) conjugates efficiently enter immune cells, silencing STAT3 and activating innate immunity to enhance T-cell mediated antitumor immune responses. In the present study, we demonstrate that blocking STAT3 through locally delivered CpG-Stat3 siRNA enhances the efficacies of the systemic PD-1 and CTLA4 blockade against mouse A20 B cell lymphoma. In addition, locally delivered CpG-Stat3 siRNA combined with systemic administration of PD-1 antibody significantly augmented both local and systemic antitumor effects against mouse B16 melanoma tumors, with enhanced tumor-associated T cell activation. Overall, our studies in both B cell lymphoma and melanoma mouse models demonstrate the potential of combinatory immunotherapy with CpG-Stat3 siRNA and checkpoint inhibitors as a therapeutic strategy for B cell lymphoma and melanoma.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation and tumor infiltration of natural killer cells 95%
- Elucidating Mechanisms of Antitumor Immunity Mediated by Live Oncolytic Vaccinia and Heat-Inactivated Vaccinia 95%
- Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells. 95%
Similar papers in this journal
- Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory 95%
- DUSP11 is an intracellular innate immune checkpoint in lung adenocarcinoma 93%
- Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects 93%
Similar papers in this journal
- Intratumoral expression of IL-12 and CD40 ligand (CD154) from plasmids generates antitumor responses that eliminate tumoral T regs 96%
- Transcriptome Profiling and Characterization of Peritoneal Metastasis Ovarian Cancer Xenografts in Humanized Mice 94%
- Development and Characterization of Patient-Derived Xenografts from Non-Small Cell Lung Cancer Brain Metastases 93%
Similar papers in this journal
- Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses 93%
- CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts 93%
- CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade 93%
Similar papers in this journal
- Repurposing Live Attenuated Trivalent MMR Vaccine as Cost-effective Cancer Immunotherapy 94%
- Pan-TREM-1 versus macrophage-restricted TREM-1 blockade in cancer and other inflammatory pathologies 93%
- A novel fully-human potency-matched dual cytokine-antibody fusion protein targets carbonic anhydrase IX in renal cell carcinomas 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.